News & Perspective

Jun 10, 2010

Jun 10, 2010

Three countries report growing flu activity

(CIDRAP News) – Some parts of India and Colombia are reporting increases in pandemic flu activity, along with some deaths, while New Zealand, which is beginning its regular flu season, is reporting a rise in flu-like illnesses, particularly in young children.

Jun 03, 2010

Jun 03, 2010

WHO advisors again hold at current pandemic phase

(CIDRAP News) – Based on an assessment of outside experts, the World Health Organization (WHO) announced today that it is sticking with its current pandemic alert level, based on recurring but low-level activity in some parts of the globe and until it has more information on the Southern Hemisphere's flu season.

Aug 28, 2009

Aug 28, 2009

WHO cites severe H1N1 cases as southern outbreaks wane

(CIDRAP News) – Novel H1N1 influenza outbreaks are starting to wane in the southern hemisphere, and while most cases are still mild, clinicians are reporting some severe cases of viral pneumonia in young, previously healthy people, the World Health Organization (WHO) said today.

Jul 23, 2009

Jul 23, 2009

WHO offices issue pandemic flu surveillance updates

(CIDRAP News) - The World Health Organization (WHO) recently posted surveillance and status updates for regions where the pandemic H1N1 is just gaining a foothold, including the Mideast, Africa, and parts of Asia and the Pacific, which showed Southeast Asia as the hardest hit of those areas.

Jul 07, 2009

Jul 07, 2009

WHO to ask countries to ease novel H1N1 testing

(CIDRAP News) – The World Health Organization (WHO) said today it will soon advise most countries to ease the volume of testing for novel H1N1 influenza and said testing related to recent oseltamivir-resistant cases has so far turned up no additional cases.

Dec 19, 2008

Dec 19, 2008

With H1N1 resistance, CDC changes advice on flu drugs

(CIDRAP News) – Increased resistance to oseltamivir (Tamiflu), the leading influenza drug, has prompted federal health officials to change their advice about flu treatment, saying clinicians for now should consider using zanamivir (Relenza) or a combination of two drugs for patients suspected of having influenza A.

Oct 31, 2008

Oct 31, 2008

Encouraging results reported for injectable flu drug

(CIDRAP News) – BioCryst Pharmaceuticals Inc. reported encouraging results this week in two phase 2 trials of its injectable antiviral drug, peramivir, a potential new treatment for influenza.

Peramivir is a neuraminidase inhibitor, like the licensed antivirals oseltamivir (Tamiflu), which is taken orally, and zanamivir (Relenza), inhaled as a powder.

Oct 27, 2008

Oct 27, 2008

Drug-resistant flu viruses cause growing concern

– WASHINGTON, DC (CIDRAP News) – Health officials worldwide are becoming increasingly concerned about influenza viruses' resistance to antiviral drugs, which can shut down a flu infection or mitigate symptoms. Flu antivirals are vital for reducing severe illness and death in average flu seasons and could be essential bulwarks against an influenza pandemic if one began.

Pages

Sort Results By:

 Sort Results By:

Narrow results by:

by country

by organization

Newsletter Sign-up

Get CIDRAP news and other free newsletters.

Sign up now»

OUR UNDERWRITERS

Unrestricted financial support provided by

Bentson Foundation 3MAccelerate DiagnosticsGilead 
Grant support for ASP provided by


bioMérieux

  Become an underwriter»